| Disruption of mitochondrial complex I induces progressive parkinsonism P González-Rodríguez, E Zampese, KA Stout, JN Guzman, E Ilijic, B Yang, ... Nature 599 (7886), 650-656, 2021 | 398 | 2021 |
| Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo KM Lohr, AI Bernstein, KA Stout, AR Dunn, CR Lazo, SP Alter, M Wang, ... Proceedings of the National Academy of Sciences 111 (27), 9977-9982, 2014 | 212 | 2014 |
| Dopamine metabolism by a monoamine oxidase mitochondrial shuttle activates the electron transport chain SM Graves, Z Xie, KA Stout, E Zampese, LF Burbulla, JC Shih, ... Nature neuroscience 23 (1), 15-20, 2020 | 152 | 2020 |
| Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease AR Dunn, KA Stout, M Ozawa, KM Lohr, CA Hoffman, AI Bernstein, Y Li, ... Proceedings of the National Academy of Sciences 114 (11), E2253-E2262, 2017 | 130 | 2017 |
| Misassembly of full-length Disrupted-in-Schizophrenia 1 protein is linked to altered dopamine homeostasis and behavioral deficits SV Trossbach, V Bader, L Hecher, ME Pum, ST Masoud, I Prikulis, ... Molecular psychiatry 21 (11), 1561-1572, 2016 | 98 | 2016 |
| The synaptic vesicle glycoprotein 2: structure, function, and disease relevance KA Stout, AR Dunn, C Hoffman, GW Miller ACS Chemical Neuroscience 10 (9), 3927-3938, 2019 | 90 | 2019 |
| The vesicular monoamine transporter 2: an underexplored pharmacological target AI Bernstein, KA Stout, GW Miller Neurochemistry international 73, 89-97, 2014 | 82 | 2014 |
| Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity KM Lohr, KA Stout, AR Dunn, M Wang, A Salahpour, TS Guillot, GW Miller ACS chemical neuroscience 6 (5), 790-799, 2015 | 76 | 2015 |
| Exposure to the polybrominated diphenyl ether mixture DE-71 damages the nigrostriatal dopamine system: role of dopamine handling in neurotoxicity JM Bradner, TA Suragh, WW Wilson, CR Lazo, KA Stout, HM Kim, ... Experimental neurology 241, 138-147, 2013 | 71 | 2013 |
| Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure LM McFadden, GC Hadlock, SC Allen, PL Vieira-Brock, KA Stout, JD Ellis, ... The Journal of pharmacology and experimental therapeutics 340 (2), 295-303, 2012 | 66 | 2012 |
| Vesicular monoamine transporter 2 (VMAT2) level regulates MPTP vulnerability and clearance of excess dopamine in mouse striatal terminals KM Lohr, M Chen, CA Hoffman, MJ McDaniel, KA Stout, AR Dunn, ... Toxicological Sciences 153 (1), 79-88, 2016 | 54 | 2016 |
| Selective enhancement of dopamine release in the ventral pallidum of methamphetamine-sensitized mice KA Stout, AR Dunn, KM Lohr, SP Alter, RA Cliburn, TS Guillot, GW Miller ACS chemical neuroscience 7 (10), 1364-1373, 2016 | 40 | 2016 |
| In Vitro and In Vivo Characterization of the Alkaloid Nuciferine MS Farrell, JD McCorvy, XP Huang, DJ Urban, KL White, PM Giguere, ... PLoS One 11 (3), e0150602, 2016 | 39 | 2016 |
| Selective D2 and D3 receptor antagonists oppositely modulate cocaine responses in mice via distinct postsynaptic mechanisms in nucleus accumbens DF Manvich, AK Petko, RC Branco, SL Foster, KA Porter-Stransky, ... Neuropsychopharmacology 44 (8), 1445-1455, 2019 | 35 | 2019 |
| Immunochemical localization of vesicular monoamine transporter 2 (VMAT2) in mouse brain RA Cliburn, AR Dunn, KA Stout, CA Hoffman, KM Lohr, AI Bernstein, ... Journal of chemical neuroanatomy 83, 82-90, 2017 | 33 | 2017 |
| Methamphetamine alters vesicular monoamine transporter‐2 function and potassium‐stimulated dopamine release PW Chu, GC Hadlock, P Vieira‐Brock, K Stout, GR Hanson, ... Journal of neurochemistry 115 (2), 325-332, 2010 | 32 | 2010 |
| A fluorescent-based assay for live cell, spatially resolved assessment of vesicular monoamine transporter 2-mediated neurotransmitter transport AI Bernstein, KA Stout, GW Miller Journal of neuroscience methods 209 (2), 357-366, 2012 | 28 | 2012 |
| Immunochemical analysis of the expression of SV2C in mouse, macaque and human brain AR Dunn, CA Hoffman, KA Stout, M Ozawa, RK Dhamsania, GW Miller Brain research 1702, 85-95, 2019 | 22 | 2019 |
| Reduced vesicular monoamine transport disrupts serotonin signaling but does not cause serotonergic degeneration SP Alter, KA Stout, KM Lohr, TN Taylor, KR Shepherd, M Wang, TS Guillot, ... Experimental neurology 275, 17-24, 2016 | 22 | 2016 |
| Methamphetamine self‐administration acutely decreases monoaminergic transporter function LM McFadden, KA Stout, PL Vieira‐Brock, SC Allen, SM Nielsen, ... Synapse 66 (3), 240-245, 2012 | 17 | 2012 |
